ARCHIVES

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

“I Can’t Permit Destruction of NSABP,” Fisher Writes

September 9, 1994

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

NCI, ACS Agree On Interim Mammography Guides Dropping Routine Use for Women Under Age 50

August 27, 1976

FDA Plans Safety Reviews Of Newly Approved Drugs; Drug Safety Bills Introduced In Senate.

February 2, 2007

Burton’s Clinic Reported Operating In Spite of Closure

December 13, 1985

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007